Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2005

Open Access 01-12-2005 | Research

New Vibrio cholerae O1 Biotype ElTor bacteriophages

Authors: Anindito Sen, Amar N Ghosh

Published in: Virology Journal | Issue 1/2005

Login to get access

Abstract

We report the presence of three new O1 ElTor vibriophages named AS1, AS2 and AS3, isolated from the sewage and pond waters of the outskirts of Kolkata. A few phages, named AS4, with hexagonal heads and abnormally long tails with typical curly projections were also found in the water samples.
Appendix
Available only for authorised users
Literature
1.
Chatterjee SN, Maiti M: Vibriophages and Vibriocins: physical, chemical and biological properties. Adv Virus Res 1984, 29: 263-312.CrossRefPubMed
2.
Ramamurthy T, Garg R, Sharma R, Bhattacharya SK, Nair GB, Simada T, Takeda T, Karasawa T, Kurazano H, Pal A, Takeda Y: Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 1993, 314: 703-704. 10.1016/0140-6736(93)90480-5CrossRef
3.
Basu S, Mukerjee S: Bacteriophage typing of Vibrio ElTor. Experimenta 1968, 24: 299-300.CrossRef
4.
Chattopadhyay DJ, Sarkar BL, Ansari MQ, Chakrabarti BK, Roy MK, Ghosh AN, Pal SC: New phage typing scheme for Vibrio cholerae O1 biotype El Tor strains. J Clin Microbiol 1993, 31: 1579-1585.PubMedCentralPubMed
5.
Chakrabarti AK, Ghosh AN, Nari GB, Niyogi SK, Bhattacharya SK, Sarkar BL: Development and evaluation of a phage-typing scheme for Vibrio choleare O139. J Clin Microbiol 2000, 38: 44-49.PubMedCentralPubMed
6.
Chakrabarti BK, Chattopadhyay DJ, Ghosh AN: Vibriophage D10 contains non-permutated DNA with cohesive ends. J Gen Virol 1993, 74: 2749-2752.CrossRefPubMed
7.
Ghosh AN, Ansari MQ, Dutta GC: Isolation and morphological characterization of El Tor cholera phages. J Gen Virol 1989, 70: 2241-2243.CrossRefPubMed
8.
Talledo M, Rivera ING, Lipp EK, Neale A, Karolis D, Huq A, Colwell R: Characterization of a Vibrio cholerae phage isolated from coastal water of Peru. Environ Microbiol 2003, 5: 350-354. 10.1046/j.1462-2920.2003.00411.xCrossRefPubMed
9.
Adams MH: Bacteriophages. Interscience publishers, Inc New York; 1959.
10.
Ackerman HW, DuBow MS: Vibriophages. In Viruses of Prokaryotes. Volume I. CRC press, Inc Florida, USA; 1987.
11.
Sarkar BL, Ghosh AN, Sen A, Rodrigues DP: Newly isolated Vibro cholerae non-O1 non-O139 phages. Emerg Infect Dis 2003, 10: 754-756.CrossRef
Metadata
Title
New Vibrio cholerae O1 Biotype ElTor bacteriophages
Authors
Anindito Sen
Amar N Ghosh
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2005
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-2-28

Other articles of this Issue 1/2005

Virology Journal 1/2005 Go to the issue

Research

Physicochemical characterization of vibriophage N5

Research

Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a Vaccinia virus recombinant

Short report

Hepatitis B virus X protein interacts with β5 subunit of heterotrimeric guanine nucleotide binding protein

Research

Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera

Commentary

International Committee on Taxonomy of Viruses and the 3,142 unassigned species

Research

Eco-epidemiological analysis of dengue infection during an outbreak of dengue fever, India
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits